Corbus Pharmaceuticals Holdings Inc. Stock Rises 5.8%, Outperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Corbus Pharmaceuticals Holdings Inc. advanced 5.8% to $11.31 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 0.7% to 26,151.30 and the Dow Jones Industrial Average rising 0.3% to 53,577.40.

This was the stock's third consecutive day of gains.

Corbus Pharmaceuticals Holdings Inc. closed 45.0% short of its 52-week high of $20.56, which the company achieved on October 20th.

The stock outperformed some of its peers, as Vanda Pharmaceuticals Inc. rose 2.1% to $5.44, Fortress Biotech Inc. fell 3.4% to $2.83, and Viking Therapeutics Inc. rose 2.83% to $34.17.

Trading volume totaled 1.3 million, compared to the 50-day average of 411,768.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

August 25, 2026 16:32 ET (20:32 GMT)